# Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis

> **NCT04480632** · PHASE2 · UNKNOWN · sponsor: **Fundación Cardiovascular de Colombia** · enrollment: 44 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Convalescent plasma

## Key facts

- **NCT ID:** NCT04480632
- **Lead sponsor:** Fundación Cardiovascular de Colombia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2021-08
- **Final completion:** 2022-08
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04480632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04480632, "Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04480632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*